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Abstract
Background: Our aim was to differentiate human (h) embryonic stem (ES) cells into lung epithelial lineage-specific cells [i.e.,
alveolar epithelial type I (AEI) and type II (AEII) cells and Clara cells] as the first step in the development of cell-based
strategies to repair lung injury in the bleomycin mouse model of idiopathic pulmonary fibrosis (IPF). A heterogeneous
population of non-ciliated lung lineage-specific cells was derived by a novel method of embryoid body (EB) differentiation.
This differentiated human cell population was used to modulate the profibrotic phenotype in transplanted animals.
Methodology and Principal Findings: Omission or inclusion of one or more components in the differentiation medium
skewed differentiation of H7 hES cells into varying proportions of AEI, AEII, and Clara cells. ICG-001, a small molecule
inhibitor of Wnt/b-catenin/Creb-binding protein (CBP) transcription, changed marker expression of the differentiated ES
cells from an AEII-like phenotype to a predominantly AEI-like phenotype. The differentiated cells were used in xenograft
transplantation studies in bleomycin-treated Rag2cC
2/2 mice. Human cells were detected in lungs of the transplanted
groups receiving differentiated ES cells treated with or without ICG-001. The increased lung collagen content found in
bleomycin-treated mice receiving saline was significantly reduced by transplantation with the lung-lineage specific
epithelial cells differentiated from ES cells. A significant increase in progenitor number was observed in the airways of
bleomycin-treated mice after transplantation of differentiated hES cells.
Conclusions: This study indicates that ES cell-based therapy may be a powerful novel approach to ameliorate lung fibrosis.
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Introduction
The pulmonary system is composed of a variety of epithelial cell
populations residing in distinct anatomical locations. Of these, the
alveolar epithelial gas exchange surface consists of two cell types,
the type I and type II pneumocytes, also known as alveolar
epithelial type I and type II (AEI and AEII) cells, that comprise
,95% and 5% respectively of the alveolar lining area [1]. AEI
cells, important in the regulation of alveolar fluid balance [2], are
branched cells with cytoplasm extremely attenuated for gas
exchange [3]. AEII cells are cuboidal cells situated between AEI
cells, and contain characteristic lamellar bodies and apical
microvilli [3]. Functions of AEII cells include the secretion and
reuptake of pulmonary surfactant [4], regulation of alveolar fluid,
and synthesis of immunomodulatory proteins [e.g., surfactant
protein (SP)-A, SP-D] important for host defense [5]. The non-
ciliated columnar Clara cells [6] constitute the majority of the
bronchiolar and terminal bronchiolar epithelium. Clara cells
actively divide and differentiate to form ciliated cells, secrete
glycosaminoglycans that are major component of the extracellular
matrix (ECM), and metabolize airborne toxins by cytochrome P-
450 enzymes present in their smooth endoplasmic reticulum [7].
In many life-threatening pulmonary diseases, such as acute lung
injury, acute respiratory distress syndrome (ARDS), cystic fibrosis,
and idiopathic pulmonary fibrosis (IPF) [8–10], endothelial cells
and AEI cells are sites of initial damage. As a result, interstitial
edema occurs, and increased deposition of ECM proteins such as
collagen, laminin, and fibronectin in the lungs resulting in
pulmonary fibrosis and loss of the gas exchange surface. For lung
injury repair, AEII cells or other lung progenitor cells may replace
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33165lost AEI cells to re-establish the thin barrier necessary for efficient
gas exchange in the alveolar milieu [11].
Human embryonic stem (hES) cells are a potential source of
cells for cell-based therapy in degenerative diseases where there is
progressive loss of functional tissue. Cellular replacement therapy
or regeneration of lost tissue may potentially reinstate normal
tissue structure and function [12,13]. For tissue replacement
therapy to be feasible, sufficient numbers of lung lineage-specific
cells need to be engineered in vitro for transplantation. A key
regulator of stem cell self-renewal with important effects on both
cell proliferation and differentiation is the Wnt/b-catenin signaling
pathway. Through this canonical Wnt signaling pathway, b-
catenin increases in the nucleus and forms a complex with T cell
factor (TCF)/lymphoid enhancer factor-1 (LEF-1) transcription
factors that are differentiately modulated by Creb-binding protein
(CBP) and p300 co-activators. An increase in b-catenin/CBP-
mediated transcription by selectively inhibiting b-catenin/p300-
mediated transcription maintains stem cell pluripotency, whereas
blockade of b-catenin/CBP signaling facilitates b-catenin/p300-
mediated transcription and cell differentiation [14–16].
Our aim was to differentiate hES cells into lung epithelial
lineage-specific cells (i.e., AEI, AEII, and Clara cells) and develop
a cell-based strategy in order to repair lung injury in a mouse
model of IPF. Previous work [17–20] has demonstrated differen-
tiation steps to AEII cells from murine ES cells and the hES H1
cell line. Bleomycin, an anti-neoplastic drug that causes lung
fibrosis as a side effect in patients, has been employed in mouse
models to induce pulmonary fibrosis. DNA damage by bleomycin
induces apoptosis of epithelial cells with loss of AEI cells in the
alveolus accompanied by interstitial deposition of collagen and
other ECM proteins. It is thought that AEII cells contribute to the
repair of the injured lungs by an initial limited proliferation
followed by differentiation to AEI cells and Clara cells. Using the
selective small molecule blocker ICG-001 that inhibits the b-
catenin/CBP interaction without blocking the b-catenin/p300
interaction, we have recently demonstrated a causal role for
aberrant Wnt/b-catenin-mediated transcription in development
and progression of pulmonary fibrotic disease in the bleomycin
mouse model [21].
In this study, we successfully differentiated hES H7 cells in
culture into non-ciliated lung lineage-specific cells with intracel-
lular and surface protein markers and morphology characteristic
of AEI cells, AEII cells, and Clara cells. The selective b-catenin/
CBP inhibitor ICG-001 facilitated the induction/differentiation of
AEII cells to AEI cells. We found the differentiated stem cells to
home to small airways of mouse lung with bleomycin-induced lung
fibrosis in a xenograft transplantation model. Engraftment of the
human cells was accompanied by marked reduction of the
increased collagen content of the injured murine lungs demon-
strating the potential role of hES cell therapy in amelioration of
pulmonary fibrosis.
Results
Differentiation of hES Cells is Accompanied by Sequential
Downregulation of Pluripotent Markers
Cells from the hES cell line H7 were differentiated in vitro into
three lung lineage-specific epithelial cells: AEI cells, AEII cells, and
Clara cells as described below. These cells expressed, both
intracellularly and on their surface, characteristic marker proteins,
detected by fluorescence-activated cell sorting (FACS) and
immunofluorescence (IF) microscopy, the mRNA for which were
also concomitantly over-expressed as detected by quantitative real-
time PCR (qPCR). The protocol for differentiation of pluripotent
undifferentiated colonies of H7 hES cells into the lung epithelial
cell-specific lineages is shown in Figure 1a. After embryoid body
(EB) formation (Figure 1b–d), EBs were cultured in EB medium
for 10 days followed by culture for an additional 12 days in either
small airways growth medium (SAGM) (Figure 1e–g)o r
bronchiolar epithelial growth medium (BEGM) (Figure 1h–j);
BEGM differs from SAGM by the presence of retinoic acid and
T3 and absence of BSA. Prior to differentiation, most H7 hES cells
expressed high percentages of the early marker of epithelial lung
differentiation TTF-1 and pluripotent markers SSEA-3, SSEA-4,
and Oct3/4 (Figure 2a–d). Following EB formation and
differentiation in adherent culture in either SAGM (Figure 2e)
or BEGM (Figure 2f), these markers were downregulated
sequentially. Of these markers, Oct3/4 was downregulated first
(15.864.3% on day 10 in EB medium from 77.968.9% positive in
the undifferentiated state) followed by TTF-1 (1262.9% on day 10
from 6863.8 in the undifferentiated state), whereas SSEA-3 and
SSEA-4 expression remained stable (54.964.0% and 51.9614.9%
respectively on day 10 in EB medium) (Figure 2a, c). During
induction of differentiation, all four markers were markedly
downregulated to ,2–8% in either SAGM (Figure 2e) or BEGM
(Figure 2f) within 24 h after transfer to adherent culture and to
,1% on day 6 in SAGM (Figure 2e) and day 11 in BEGM
(Figure 2f).
Variation in Growth Media Skews Differentiation of hES
Cells to AEI Cell, AEII Cell, and Clara Cell Phenotypes
Phenotypic analysis of cells by intracellular and surface marker
expression was used to identify lung lineage-specific epithelial cells
differentiated from H7 hES cells in either SAGM or BEGM:
aquaporin-5 (AQP-5) for AEI cells, SP-C for AEII cells, and Clara
cell-specific protein-10 (CC-10) for Clara cells. Cells differentiated
in SAGM were predominantly AEII cells (Figure 3a–d, i, j).
Kinetics of marker expression of the cells over a period of 12 days,
identified them as 68.0% AEII cells, 11.7% AEI cells, and 3.9%
Clara cells (Figure 3a). Representative FACS scattergrams of
cells cultured in SAGM are shown in Figure S1. mRNA
expression of SP-C was increased by 15-fold, AQP-5 by 1.3-fold,
and CC-10 by 2.7-fold from the initial differentiation stage
(Figure 3b). However, when the same culture steps were followed
but the induction medium was changed to BEGM (Figure 3e–h,
k), the hES cells differentiated into 32.6% Clara cells, 12.4% AEII
cells, and 2.2% AEI cells with concomitant increase in mRNA
expression of CC-10 (6-fold), SP-C (3-fold), and AQP-5 (1.3-fold).
By transmission electron microscopy, the predominant cells
differentiated in SAGM exhibited the typical morphology of AEII
cells (Figure 3i) including lamellar bodies (Figure 3i, j), whereas
those in BEGM had secretory granules characteristic of Clara cells
(Figure 3k).
Inhibition of Wnt/b-catenin/CBP Signaling Promotes
Differentiaton of hES Cells to AEI Cell Phenotype
We examined whether the selective b-catenin/CBP inhibitor
ICG-001 [22] would modulate the differentiation of undifferen-
tiated hES cells to AEI cells, AEII cells, or Clara cells. As data
from independent experiments indicated, incubation of day 12
SAGM-differentiated cells with ICG-001 (5 mM) for 12 h induced
differentiation/trans-differentiation of AEII cells to the AEI cell
phenotype. Following treatment with ICG-001, there was a
significant decrease in AEII cells cultured in either SAGM
(Figures 4 and S2) or BEGM (Figure S3) as determined by
both intracellular (Figures 4a and S3a) and surface (Figures 4b
and S3b) SP-C
+ marker expression. In contrast, AEI cells
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determined by intracellular (Figures 4a and S3a) and surface
(Figures 4b and S3b) AQ-5
+ expression. The number of Clara
cells as assessed by CC-10
+ expression was unaffected by Wnt- b-
catenin inhibitor treatment in either SAGM (Figure 4a, b)o r
BEGM (Figure S3a, b). Morphologically, an increase in more
flattened cells with larger surface area typical of AEI cells was seen
in cells cultured in either SAGM (Figure S2b, c) or BEGM
(Figure S3f) after incubation with ICG-001.
We next examined the effect of modulating Wnt/b-catenin
signaling on pluripotent marker expression in hES cells differen-
tiated in SAGM or BEGM: c-kit
+ (i.e., marker for hematopoietic
stem cells as well as early thymocytes, mast cells, melanocytes in
skin, and interstitial cells of Cajal), Lin
2 (i.e., lineage-negative cells
that are the traditionally considered as pluripotent cells without
expression of lineage markers), and Oct3/4
+ (expressed universally
on pluripotent stem cells). Expression of these pluripotent markers
was not significantly affected by modulation of Wnt-b-catenin
signaling in cells cultured in either SAGM (Figure 4d) or BEGM
(Figure S3c) except for decreased c-kit
+ cell number in the cell
population cultured in BEGM (Figure S3c). The effect of ICG-
001 on surface expression of epidermal growth factor (EGF),
vascular endothelial growth factor (VEGF), and insulin-like growth
factor II (IGFII) was examined by FACS and IF microscopy. Wnt/
b-catenin inhibition by ICG-001 induced increased expression of
EGF
+ and VEGF
+ cells in both SAGM and BEGM, but did not
affect the percentage of IGFII
+ cells (Figures 4e and S3d).
Clonogenic Potential of hES Cells Declines with
Differentiation
Lung progenitors are pluripotent cells in the lung. The source of
these cells is unclear. We assessed clonogenic potential of
hematopoietic progenitor cells by plating cells from either
undifferentiated ES or EB samples, or differentiating EB in
Figure 1. Differentiation of H7 hES cells to lung epithelial cell-specific lineages. a Outline of formation of EBs from H7 hES cells and
differentiation to alveolar epithelial cells in SAGM and BEGM. b Undifferentiated hES cells (within circle) were expanded on c-irradiated MEF feeders
for 4–6 days followed by formation of c EBs in suspension culture overnight after aggregation. d day 4 EBs were cultured in ultra-low attachment
plates for 10 days and then transferred to gelatin-coated plates and cultured with either e–g SAGM or h–j BEGM for 12 days (g and j are insets of SP-
C-FITC
+ cells). AEII cells were flow sorted as surface SP-C
+ cells and enriched in SAGM for an additional 4 days to amplify cell numbers for
transplantation. At each stage, cells were fixed in chamber slides for IF microscopy [green probe is FITC-conjugated lineage (epithelial) marker and
blue probe is DAPI-stained nuclei of live cells]. f, g show enriched AEII cells and i, j Clara cells. All the steps were performed in three independent
experiments, and the results were reproducible.
doi:10.1371/journal.pone.0033165.g001
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Viable colonies (i.e., 10
5 cells were plated from which after growth,
colonies with .40 cells were considered for evaluation) increased
from 9963 at day 1 (D1ES, Figure 5) to 13063 on day 7 (D7ES,
Figure 5) in ES cell medium. As seen in Figure 5, a significant
decrease in clonogenic potential (as compared to D1ES) was
observed in hES cells as they formed EBs (D2EB and D4EB) with
the decline progressing as they differentiated in either SAGM
(D6SAGM and D12SAGM) or BEGM (D8BEGM and
D12BEGM).
Engraftment of Differentiated hES Cell Transplants in
Mice with Lung Fibrosis
H7 hES cells differentiated into lung epithelial cell-specific
lineages were transplanted into bleomycin-treated mice to
determine whether they would home to injured lung and reduce
pulmonary fibrosis. To avoid rejection of the human xenograft
cells, sub-lethally irradiated immunocompromised mice (i.e.,
Rag2cC
2/2) were used. The differentiated stem cells were
delivered by the intratracheal route as we anticipated that the
site of injury would facilitate directed migration of the cells
towards the fibrotic lesions within the lungs. On day 7 after
bleomycin treatment, Rag2cC
2/2 mice received a single
intratracheal instillation of 10
5 cells from the day 12 culture in
SAGM without (i.e., Bleo/hES+SAGM group) or with 5 mM
ICG-001 (i.e., Bleo/hES+SAGM+ICG-001 group) treatment.
Control groups of saline-treated mice (i.e., Saline group) and
bleomycin-treated mice (i.e., Bleo/Saline group) received saline
intratracheally on day 7. Cells differentiated in BEGM were not
employed in these transplantation studies because culture in this
growth medium resulted in differentiation into predominantly
Clara cells that are found in terminal bronchioles and thus unlikely
to be suitable for treatment of an alveolar destructive disease
typified by the mouse bleomycin model of pulmonary fibrosis.
Engraftment of the transplanted human cells in the airways of
bleomycin-treated mice was observed in each of the transplant
groups. Human cells (from transplants of ES cells differentiated in
SAGM alone or SAGM+ICG-001) were detected in mouse
airways by immunocytochemistry using anti-human nuclear factor
antibody (Figure 6c), qPCR of human Alu sequence (Figure 6h),
and in situ hybridization with human-specific pan-centromeric
probe (Figure 6l). Similarly, hES cells differentiated in SAGM in
Figure 2. Sequential downregulation of stem cell-specific surface proteins. a–d H7 hES cells were cultured in SAGM or BEGM as described
in Figure 1 and made into single cell suspensions and analyzed by FACS. a Surface expression of TTF-1, Oct3/4, SSEA-3, and SSEA-4 markers in
undifferentiated H7 hES cells over 3 days in c-irradiated MEF-conditioned media. b Representative FACS scattergram for Oct3/4 and TTF-1 of
undifferentiated day 1 hES cells is shown with the percentage of cells gated in each quadrant as follows: upper left (UL), 74.27%; upper right (UR),
25.73%; lower left (LL), 0%; and lower right (LR), 0%. c EBs grown in suspension culture. d Representative FACS scattergram for SSEA-3 and SSEA-4 of
day 2 EBs are shown with the percentage of cells gated in each quadrant as follows: UL, 3.5%; UR, 96.47%; LL, 0.02%; and LR, 0.01%. Adherent culture
was in either e SAGM or f BEGM. Symbols: -&-, TTF-1; %-, Oct3/4; -???-, SSEA-3; -e-, SSEA-4 for identification of differentiation stage of the cells in
culture. The percentage of positive cells is shown as mean 6 SEM (n=3 independent experiments with flow data collected in triplicate). e, f The
asterisk indicates that all values were significant (P,0.05) compared to day 0 for e days 6–12 and f days 8–12 in adherent culture for each of the
markers (i.e., TTF-1, Oct3/4, SSEA-3, and SSEA-4). The individual P,0.05 values for these marker data points are shown in Table S2.
doi:10.1371/journal.pone.0033165.g002
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methods (Figure 6d, i, m). After intratracheal instillation of the
hES cells differentiated in SAGM without or with ICG-001
treatment, no human cells were detected in kidney, liver, heart,
spleen, bone marrow, or peripheral blood by the qPCR assay of
human ALU. Further, analysis of bone marrow, blood, and spleen
by FACS with human specific antibodies also failed to detect the
presence of human cells indicating that the homing and
engraftment of the differentiated hES cells was likely restricted
to the airways.
Differentiated hES Cell Transplants Reduce Pulmonary
Inflammation and Fibrosis Induced by Bleomycin
The effect of human stem cells differentiated in SAGM in the
absence or presence of treatment with the Wnt/b-catenin inhibitor
ICG-001 on bleomycin-induced lung injury was determined
(Figure 7). Pulmonary pathology in the bleomycin-treated
immunocompromised Rag2cC
2/2 control mice showed a) airway
inflammation, as assessed by histology (Figure 7b) and increased
levels of mononuclear and polymorphonuclear leukocytes in BAL
fluid (Bleo/Saline group, Figure 7i), and b) alveolar and
interstitial fibrosis, as assessed by Masson’s trichrome
(Figure 7b) and Picro Sirius red (Figure 7f) staining and
increased collagen content (Bleo/Saline group, Figure 7j)
compared to saline-treated controls (Figure 7a, e and Saline
group, Figure 7i, j).
The bleomycin-induced airway inflammation and fibrosis
induced in Rag2cC
2/2 mice was comparable to that seen in
wild-type controls (not shown). Significant reduction of inflamma-
tory cells in BAL fluid and collagen content per lung was observed
in the recipient groups receiving hES cells differentiated in either
SAGM alone (Figure 7c, g and Bleo/hES+SAGM group,
Figure 7i, j) or in presence of ICG-001 (Figure 7d, h and
Bleo/hES+SAGM+001 group, Figure 7i, j). The increased
collagen (i.e., Col1a2, Col3a1, and Col6a1) gene expression found
in the lungs of bleomycin-treated control mice (Bleo/Saline group,
Figure 7k) compared to saline-treated controls (Saline group,
Figure 7k) was significantly decreased in recipients of H7 hES
cells differentiated in SAGM in the absence (Bleo/hES+SAGM
group, Figure 7k) or presence of ICG-001 treatment (Bleo/
hES+SAGM+001 group, Figure 7k). Similarly, the increased
expression of transforming growth factor (TGF) genes (i.e.,
TGFb1, TGFb2, and TGFb3; Bleo/Saline group, Figure 7l),
fibroblast growth factor (FGF) genes (i.e., FGF-1 and FGF-2;
Figure 3. Phenotypic analysis and ultrastructure of hES cells differentiated to lung epithelial cell-specific lineages. EBs derived from
H7 hES cells were allowed to form outgrowths and differentiate in EB medium over 10 days and then cells cultured over 12 days in either a–d, i, j
SAGM or e–h, k BEGM. Expression of intracellular marker proteins was quantitated by a FACS analysis of single cell suspensions and e IF microscopy
with anti-AQP-5, SP-C, and CC-10 monoclonal antibodies used to identify AEI cells, AEII cells, and Clara cells respectively. The mean percentage
positive of total cells is shown 6 SEM. b, f qPCR of mRNA of AQP-5, SP-C, and CC-10 normalized to human GAPDH is expressed as relative units 6
SEM. Symbols: -???-, AQP-5; -&-, SP-C; -N-, CC-10. a, b, e, f The data are reported as mean 6 SEM; n=3 independent experiments with a flow data
collected in triplicate and b, f qPCR and e IF data collected in duplicate. The asterisk indicates that all values were significant (P,0.05) for a, b SP-C
and e, f CC-10 for days 4–12 in culture when compared against day 0. The individual P,0.05 values for days 4–12 in culture for the marker data points
are shown in Table S3. c, g H7 hES cells differentiated into epithelial cells viewed at 106magnification with d SP-C-FITC
+ and h CC-10-FITC
+ cells
shown by IF microscopy. i, j As seen by transmission electron microscopy, representative AEII cells grown in SAGM at day 12 contain characteristic
cytoplasmic lamellar bodies (i, arrows, scale bar=1 mm and j, scale bar=200 nm). k Clara cell grown in BEGM at day 12 by transmission electron
microscopy exhibit apical microvilli on cell surface (arrows) and electron dense secretory vesicles (circle), scale bar=0.5 mm.
doi:10.1371/journal.pone.0033165.g003
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factor (VEGF) genes (i.e., VEGF-A, VEGF-B, and VEGF-C;
Bleo/Saline group, Figure 7n) seen in bleomycin-treated mice
compared to saline-treated controls (Saline group, Figure 7l–n)
was reduced by transplantation of the H7 hES cells differentiated
in SAGM in the absence (Bleo/hES+SAGM group, Figure 7l–n)
or presence of ICG-001 (Bleo/hES+SAGM+001 group,
Figure 7l–n). Teratoma formation was not observed in the lungs
or other tissues of the Rag2cC
2/2 mice transplanted with H7 hES
cells differentiated in SAGM in the absence or presence of ICG-
001.
Differentiated hES Cell Transplants Increase Airway
Epithelial Cells and Progenitors in Mice with Pulmonary
Fibrosis
After enzymatic digestion of lung tissue by collagenase type IV
treatment, FACS analysis was performed to quantitate AEII cells
(i.e., SP-C
+), AEI cells (i.e., AQP-5
+), and Clara cells (i.e., CC-10
+).
AEII cells decreased from 7% at baseline to 2% by day 14 post-
bleomycin administration (Figure 8a). AEI cells decreased from
72% on day 0 to 53% on day 7 and 31.5% on day 14 post-
bleomycin treatment (Figure 8a). By day 14, AEI cells increased
significantly in the bleomycin-treated groups receiving transplants
of H7 hES cells differentiated in SAGM in the absence or presence
of treatment with ICG-001. On day 14, the number of Clara cells
in the transplant groups was not changed compared to bleomycin-
treated controls administered saline instead of human cells on day
7( Figure 8a). Gene expression for marker proteins for AEI cells
(i.e., AQP-5
+), AEII cells (i.e., SP-C
+), and Clara cells (i.e., CC-
10
+) was also performed (Figure 8b). Compared to the
bleomycin-treated control group (without transplantation of
human cells), expression of AQP-5 and SP-C was increased in
both transplanted groups (Figure 8b). Increased CC-10 expres-
sion was observed only in bleomycin-treated recipients of hES cells
differentiated in SAGM and treated with ICG-001 (Figure 8b).
Quantitation of colony forming units in culture (CFU-C) in
bone marrow, spleen, lung and BAL fluid of bleomycin-treated
Rag2cC
2/2 mice in the transplant groups was assessed
(Figure 8c). In comparison to bleomycin-treated controls given
saline, the number of progenitors significantly increased in the
bone marrow, blood, spleen, lung, and BAL fluid of both
transplant groups of cells differentiated in SAGM in the absence
or presence of ICG-001; lung progenitors were markedly increased
in the SAGM + ICG-001 group compared to the SAGM alone
Figure 4. Effect of ICG-001 on differentiation of hES cells in SAGM to AEI cells. Single cell suspensions of H7 hES cells differentiated in
SAGM were incubated with 5 mM ICG-001 in culture medium for 12 h and assayed by FACS to identify percentage of AEII cells (SP-C
+), AEI cells (AQP-
5
+), and Clara cells (CC-10
+). Percentage of total cells in culture of cells positive for a intracellular and b surface expression of AEI cell, AEII cell, and
Clara cell markers. Surface expression of d pluripotent markers for hematopoietic cells (c-kit
+), lineage-negative (Lin
2) cells, and Oct3/4
+ pluripotent
cells, and e growth factors (EGF
+, VEGF
+, IGFII
+). The percentage of positive cells of total cells in culture is shown as mean 6 SEM (n=three
independent experiments with FACS analyses performed in triplicate). P,0.05 values in ICG-001-treated group (open bars) vs. ICG-001-untreated
group (solid bars) are shown. Representative FACS scattergrams with the percentage of cells gated in each quadrant shown for expression of c AQ-5
(UL, 0.03%; UR, 5.08%; LL, 4.92%; and LR, 89.97%) and e: Oct3/4 and VEGF (UL, 1.47%; UR, 0.53%; LL, 86.15%; and LR, 11.85%).
doi:10.1371/journal.pone.0033165.g004
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peripheral blood of the SAGM 6 ICG-001 transplant groups
was not significantly different from the bleomycin-treated control
group administered saline (Figure 8c). In exclusively hematopoi-
etic tissues [i.e., bone marrow and peripheral blood, we detected
all of the following: CFU-E (colony-forming unit-erythroid),
BFU-E (burst-forming unit-erythroid), CFU-G (colony-forming
unit-granulocyte), CFU-M (colony-forming unit-macrophage),
CFU-GM (colony-forming unit-granulocyte/macrophage), and
CFU-GEMM (colony-forming unit-granulocyte/erythroid/mac-
rophage/megakaryocyte). In lung tissue and BAL fluid, CFU-M
and CFU-GM were detected.
Discussion
This study describes a novel strategy for differentiating hES cells
into endodermal lung lineage-specific cells. Alteration of the
differentiation medium strikingly modified the pathway of
differentiation of EBs into different cell types. Culture of EBs in
a commercially available medium used for maintaining primary
culture of mature pulmonary alveolar cells SAGM (excluding tri-
iodothyronin and retinoic acid) promoted a predominantly AEII
cell phenotype. In contrast, culture in a commercially available
BEGM (with tri-iodothyronin and retinoic acid but without BSA)
promoted differentiation to predominantly bronchiolar alveolar
cell (i.e., Clara cell) phenotype. Lung lineage-specific cell
differentiation was achieved in a relatively shorter span of time
(22 days) in contrast to other reported lung lineage culture
conditions [23]. These culture media, normally used to maintain
and grow mature cells, could successfully induce differentiation of
pluripotent embryonic stem cells into three types of mature lung
lineage-specific non-ciliated cells. Whereas AEI cells and AEII
cells are found in the alveolar areas, Clara cells are found in
terminal bronchioles. This study demonstrates that from the same
clonal population of undifferentiated hES cells, tissue engineering
can be used to skew differentiation into one or another type of
functionally competent mature cells and that blocking the b-
catenin/CBP interaction without interfering with the b-catenin/
p300 interaction by the selective Wnt/b-catenin inhibitor ICG-
001 induces induction/differentiation from one differentiated cell
type into another.
Ultrastructure of the cells by transmission electron microscopy
indicated that AEII cells derived from the hES cells had
characteristic lamellar bodies in their cytoplasmic vacuoles and
Clara cells had characteristic secretory granules. The undifferen-
tiated H7 cells were cultured not on a feeder of irradiated MEFs as
is the usual practice but in a MEF-conditioned media that
maintained a pure human cell population to be used in
transplantation studies to enable detection of the xenograft in
recipient mouse tissue without mouse feeder fibroblast contami-
nation. We observed that the percentage of differentiated AE cells
was not as high as 68% when the culture time in EB was shortened
and may explain why EBs are an essential intermediate step before
pluripotent cells may be induced to differentiate in differentiation
medium. The sequential downregulation of the pluripotent
markers SSEA-3, SSEA-4, and Oct3/4 indicated that the
mechanisms controlling the differentiation process follow a
hierarchial order in the process of differentiation, and these
proteins may play key roles in deciding the fate of the cell. Oct3/4
is a mammalian transcription factor expressed by early embryo
cells and germ cells. It is essential for the identity of the pluripotent
founder population in the mammalian embryo and required to
sustain stem cell self-renewal [24,25]. Indeed there have been
reports that transient over-expression of Oct3/4 leads to massive
epithelial hyperplasia that resolves after Oct3/4 expression is
switched off, and the expanded pools of tissue-specific progenitor
cells differentiate normally [26,27]. The sequence of downregu-
lation of the pluripotent markers before induction of differentiation
may be key in endodermal lineage differentiation (Figure 3).
SSEA-3 and SSEA-4 are characteristic markers of the H7 cell line
that does not express SSEA-1. Both SSEA-3 and SSEA-4 showed
a less rapid downregulation while still in the EB medium and
percentage positive cells at day 10 are ,50% of the total
population. This may indicate a regulatory mechanism by these
proteins that may delay either ectodermal or mesodermal
differentiation. TTF-1 (thyroid transcription factor-1) plays an
important role in lung development (co-expression of TTF-1 and
SP-C and branching morphogenesis in lung. [28,29]. TTF-1
exhibits a similar rapid downregulation by day 10 in EB medium
and may also be a necessary signal for endodermal differentiation
to follow.
Detailed characterization of the differentiated cells and the
kinetic profile of lineage-specific marker upregulation showed that
as the ES cells differentiated into AEII cells as indicated by the
markedly increased expression of SP-C marker protein for AEII
over time in culture, those for AEI cells (AQP-5
+) and Clara cells
(CC-10
+), maintained a relatively low expression. It is possible that
the cell type found to have been preferentially differentiated may
secrete factors suppressing differentiation into another cell type.
The decreased clonogenic potential of EBs from their undifferen-
tiated precursors suggests a control mechanism operative during
this stage that favors differentiation over proliferation. These
results indicate that differentiated cells derived from the hES cells
are likely incapable of proliferation on their own once terminally
differentiated or their colony forming power may be compromised
upon terminal differentiation.
This study demonstrated that ICG-001, a specific inhibitor of
the Wnt-b catenin pathway induced differentiation of AEII cells to
AEI cells, identified by characteristic marker antigens using FACS,
Figure 5. Clonogenic potential progressively declines with
increasingly differentiated state of H7 ES cell-derived lung
cells. Clonogenic potential was determined in single cell suspensions
of undifferentiated H7 ES cells on days 1 and 7 of culture in ES cell
medium (i.e., D1ES and D7ES), EBs on day 2 and 4 of culture in EB
medium (i.e., D2EB and D4EB), cells from 6 and 12 days of culture in
SAGM (i.e., D6SAGM and D12SAGM), and cells from 8 and 12 days in
culture in BEGM (i.e., D8BEGM and D12BEGM). Colony forming assays
were done with single cell suspensions from each stage in culture and
performed in duplicate. Numbers represent colonies counted per 10
5
cells plated in duplicate after 7 days in culture. The results represent
counts from 3 independent experiments as mean 6 SEM. P value,0.05
was considered significant, compared to colony forming unit (CFU)s
from D1ES cells in undifferentiated state.
doi:10.1371/journal.pone.0033165.g005
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protocol, pluripotent cells were first differentiated to AEII and
AEI cells in SAGM and then ICG-001 likely differentiated some of
the differentiated AEII cells to AEI cells by a trans-differentiation
process. The Wnt/b-catenin or canonical Wnt signaling pathway
is characterized by the nuclear accumulation of b-catenin, where it
forms a complex with members of the T cell factor (TCF)/
lymphoid enhancer factor-1 (LEF-1) family of transcription factors
[reviewed in [30]]. b-catenin subsequently recruits the transcrip-
tional coactivators, Creb-binding protein (CBP) or p300 [31,32].
Despite the fact that they are highly homologous, recent
investigations demonstrate that b-catenin/CBP and b-catenin/
p300 transcriptional complexes regulate unique subsets of genes.
Further, a switch from b-catenin/CBP to b-catenin/p300-driven
transcription is associated with the initiation of differentiation
[15,16,33]. Wnt/b-catenin signaling promotes self-renewal in a
variety of tissue stem cells, including neuronal stem cells and
hematopoeitic stem cells [34]. However, activation of the Wnt/b-
catenin pathway can either promote or inhibit differentiation
depending on the experimental circumstances [35–37]. To explain
these dichotomous activities of Wnt signaling, recent data indicate
that b-catenin/CBP-driven transcription is critical for proliferation
without differentiation (e.g., in both normal and cancer stem/
progenitor cells); whereas a switch to b-catenin/p300-mediated
gene expression is an essential first step in initiating normal cellular
differentiation [15,16,22,33]. Since we found recently ICG-001 to
reverse fibrosis in a bleomycin-induced lung fibrosis model in mice
[21], we examined its effect on hES cell differentiation.
Surprisingly, ICG-001 reduced the 68% (SP-C
+) AEII cells in
the heterogeneous cell population in SAGM to 42.5% with a
simultaneous increase of the percentage of AQP-5
+ AEI cells from
12% to 27% by intracellular staining (Figure 4a). In BEGM, the
AEII population decreased from 19% to 5%, whereas AEI cells
increased from 5% to 17% (Figure S3a). Of note, the Clara cell
percentage remained unaltered by ICG-001 in both SAGM
(Figure 4a) and BEGM (Figure S3a). These results indicate that
ICG-001 induces differentiation of AEII cells to AEI cells.
We used a mouse transplantation model of bleomycin-induced
lung fibrosis to test whether the lung epithelial cells derived from
the hES cells would home to the injured airways and ameliorate
pulmonary fibrosis. Rag2cC
2/2 mice were chosen as recipients as
they were found to be ideal candidates for xenograft transplan-
tation and they were further sub-lethally irradiated to decrease the
participation of the recipient’s own progenitor population either in
the lung itself or from bone marrow or from other adult tissues and
also to reduce the probability of a graft rejection. Differentiation of
Figure 6. Detection of human cells in lungs of bleomycin-treated mice transplanted with differentiated H7 hES cells. The presence of
human cells in the lungs of bleomycin-treated mice transplanted with differentiated H7 hES cells was assessed by a–d DAB immunocytochemistry
using anti-human nuclear factor antibody on fresh OCT-fixed cryosections, e–i qPCR of human Alu sequence, and j–m in situ hybridization with
human pan-centromeric probe. The following groups of Rag2cC
2/2mice were studied: bleomycin-treated mice administered intratracheally b, g, k
(106magnification) saline (Bleo/Saline group) or 10
5 H7 hES cells differentiated in SAGM in the c, h, l (606magnification) absence (SAGM group) or
presence of d, i, m (106magnification) 5 mM ICG-001 (SAGM+ICG-001 group). a, e positive control of H7 hES cells. f, j (606magnification) negative
control of mice given only saline intratracheally. a–d brown reaction indicate human nuclear-specific antibody staining. 606magnification. e–i qPCR
was run using the Alu-specific primer with dissociation curves shown. l and m brown stains indicate DAB-positive pan-centromeric probe reactions.
The data are representative of three independent experiments with n=4 mice per study group in each experiment.
doi:10.1371/journal.pone.0033165.g006
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consisted of a, e, i–n saline-treated control Rag2cC
2/2 mice (Saline group), c, g, i–n bleomycin-treated Rag2cC
2/2 mice administered saline (Bleo/
Saline group), and bleomycin-treated Rag2cC
2/2 mice transplanted with 10
5 H7 hES cells differentiated in SAGM in the either the c, g, i–n absence
(Bleo/hES+SAGM group), or d, h, i–n presence of 5 mM ICG-001 (Bleo/hES+SAGM+ICG-001 group) were stained with either a–d Masson’s trichrome or
e–h Picro Sirius red staining for collagen. 606magnification. i shows BAL fluid cell counts for macrophages (solid bars), lymphocytes (hatched bars),
and neutrophils (open bars) and j total soluble collagen/lung measured by the Sircol
TM assay. k–n show expression by qPCR in relative units of the
following genes: k collagen genes 1a2, 3a1, and 6a1 [Col 1a2 (white bars), Col 3a1 (black bars), Col 6a1 (gray bars)], l [TGFb1 (white bars), TGFb2
(black bars), and TGFb3 (grey bars)], m FGF [FGF-1 (white bars) and FGF-2 (black bars)], and n VEGF [VEGF-A (white bars), VEGF-B (black bars), and
VEGF-C (gray bars)]. P,0.05 values compared to bleomycin-treated control group administered saline are shown. Three independent experiments
were performed with n=4 mice per study group in each experiment. i BAL fluid counts and k–n qPCR data were performed in duplicate, and j
collagen levels were measured in triplicate.
doi:10.1371/journal.pone.0033165.g007
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PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e33165Figure 8. Effect of differentiated H7 hES cells on airway epithelial cells and progenitors in bleomycin-treated mice. Lungs of control
(saline-treated) Rag2cC
2/2 mice (Saline group), bleomycin-treated Rag2cC
2/2 mice administered saline (Bleo/Saline group), and bleomycin-treated
Rag2cC
2/2 mice transplanted with 10
5 H7 hES cells differentiated in SAGM in the either the absence (Bleo/hES+SAGM group), or presence of 5 mM
ICG-001 (Bleo/hES+SAGM+ICG-001 group) underwent a FACS or b qPCR analyses for expression of AQP-5, SP-C, and CC-10 markers of AEI cells, AEII
cells, and Clara cells respectively. a Percent positive cells in lung tissues digested by collagenase type IV treatment for FACS analysis of alveolar
epithelial cells 6 SEM. n=4 per group. *P value,0.05 compared to d 14 bleomycin-treated non-transplanted mouse lung. Symbols used are: CC-10
(solid bars), AQP-5 (open bars), and SP-C (hatched bars). b Lung tissue was homogenized, total RNA extracted, and mRNA expression for AQ-5, SP-C,
and CC-10 detected by qPCR as calculated by relative index of Ct values normalized to GAPDH by qPCR and shown as relative units. P,0.05
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hematopoietic progenitors (i.e. BFU-E, CFU-E, CFU-G, CFU-M,
CFU-GM, and CFU-GEMM) in all compartments (i.e., bone
marrow, spleen, lung, and BAL fluid) except blood ex vivo.W e
detected CFU in various tissue compartments from the bleomycin-
treated mice administered the lung-lineage differentiated hES cell
transplants. Specifically, hematopoietic-like colonies were detected
in bone marrow and blood and both epithelioid-like and
hematopoietic-like colonies were detected in the tissues of the
lung and BAL fluid of transplant recipients (Figure 8). The fact
that they were able to grow colonies in methylcellulose indicates
that they are progenitors. Treatment with ICG-001 led to a
further marked increase in progenitors in the lungs. Since
transplanted mice were not exposed to ICG-001 in vivo, this
suggests that in vitro modification of the cells led to a persistent
influence on progenitor number in widespread organs. We
hypothesize that homed hES cell-derived lung epithelial cell
lineage-specific cells may either influence the local cells to
proliferate at a higher rate or by a paracrine effect to modulate
the secretion of key growth factors and stromal components that
favor a) regeneration of lost functional tissue and b) increased
turnover of ECM proteins that are hallmarks of a profibrotic
process. This was indicated by RT-PCR analyses showing
significant reduction in ECM (i.e., collagen and fibronectin) and
profibrotic (i.e., TGFb, FGF, and VEGF) genes in the lungs of
bleomycin-treated mice transplanted with hES cells differentiated
in SAGM in either the absence or presence of ICG-001.
Previous engraftment studies in the lungs and other organs have
shown that extraneously administered cells have the capacity to
home to and expedite the repair process during injury [23,38–42].
Studies with ciliated cells in pulse chase experiments have shown
that ciliated cells transiently change their morphology but do not
proliferate or trans-differentiate in response to lung injury as part
of the repair process [43]. Non-ciliated pulmonary lineage-specific
cells however, show both proliferation and trans-differentiation but
not alteration in morphology. Our study corroborates this recent
finding. Since this was a short-term engraftment experiment and
the cells had only a week to home and engraft, true engraftment
into lung tissue may not have occurred. Alternatively, the
differentiated human cells homing to the foci of injury and
fibrosis, mainly in the smaller airways may have fused with local
cells there. This homing of cells to the foci of injury in the small
airways was associated with down-modulation of the composite
profibrotic phenotype in the injured lung. No teratoma formation
in the transplanted tissue was observed.
In summary, using a xenograft transplantation model, we have
demonstrated that differentiated lung cells derived from hES cells
can reverse fibrosis by homing to airways. The engrafted cells may
reduce fibrosis either by directly replacing fibrotic tissue or
indirectly by paracrine secretion of factors that reduce deposition
of collagen and other ECM components. This engraftment was
also associated with increased levels of AEI and AEII cells and
progenitors in the lungs. The data suggest that there are
circulating progenitors of both hematopoietic and non-hemato-
poietic origin that have been mobilized from their respective
niches in bone marrow or adult tissue (e.g., splenic lymphoid tissue
or the lung) that home to the injured lung via the systemic and
pulmonary circulation. These studies are an important step toward
development of cell-based therapy to potentially replenish
damaged tissue in acute or chronic lung injury.
Materials and Methods
Ethics Statement
All animal work was conducted according to relevant national
and international guidelines as approved by the University of
Washington Institutional Animal Care and Use Committee
(IACUC) under Protocol Number 2164-04.
Expansion of H7 hES Cells
NIH approved (NIH code WA07) undifferentiated hES cell line
H7 was obtained from WiCell Research Institute (Madison, WI)
[44], and cells from passage 25 to 35 were used. For propagation
of the H7 cells in undifferentiated state, the ES cells were initially
grown on primary mouse embryonic fibroblast (MEF) feeder cells
prepared from timed pregnant CF-1 female mice (day 13.5 of
gestation) that had been c-irradiated with 3000 rads for 5 min,
and then directly in conditioned medium in which the above c-
irradiated MEF cells were cultured to ensure purity of human cells
and progressively eliminate any mouse feeders from the cultures.
The medium contained Dulbecco’s Modified Essential Medium
(DMEM), 10% heat-inactivated fetal bovine serum (FBS), and
2 mM L-glutamine as described previously [45]. The hES cells
were cultured in ES medium [i.e., knockout (KO) DMEM
supplemented with 20% knock-out serum replacement (KOSR;
Invitrogen, Carlsbad, CA), 1 mM sodium pyruvate, 0.1 mM 2b-
mercaptoethanol (ME) (Sigma-Aldrich Corporation, St Louis,
MO), 0.1 mM minimum essential media (MEM), 1% nonessential
amino acids (NEAA; Mediatech, Herndon,VA), 1 mM L-gluta-
mine, and 2 ng/ml basic fibroblast growth factor (bFGF) (R&D
Systems, Minneapolis, MN)]. For cell culture, 6-well 10 cm
2 tissue
culture plates, coated with 0.1% gelatin were used, and all cultures
were done in a humidified 5% CO2 incubator at 37uC. The
protocol for induction of alveolar epithelial differentiation of hES
cells was adapted from established methods [17,19,46], as shown
in Figure 1a.
Embryoid Body Formation
On the day of passage, hES cell colonies were inspected, and
only hES cell cultures containing colonies with well-defined
boundaries and minimum differentiation were used. Undifferen-
tiated hES cells were treated with 1.2 U/ml dispase (Invitrogen)
dissolved in Ca
2+- and Mg
2+-free phosphate-buffered saline (PBS;
Mediatech) supplemented with 10% ES cell-qualified fetal bovine
serum (FBS; Invitrogen) at 37uC until the hES cell colonies nearly
detached from the plates. Colonies were then washed off the
plates, washed twice in ES cell medium without bFGF, and
resuspended in EB medium [i.e., KO DMEM, 20% KOSR, 20%
non-heat-inactivated fetal calf serum, 1% NEAA, 1 mM L-
glutamine, and 0.1 mM 2b-ME]. Cells were transferred to
Corning 6-well ultra-low attachment plates (Corning Inc. Life-
compared to bleomycin-treated non-transplanted lung values are shown. c To quantitate hematopoietic progenitors, CFU-C were counted after
culture in semi-solid methylcellulose from bone marrow, blood, spleen, lung, and BAL fluid obtained from the study groups. 7 days after culture, the
number of bone marrow cell CFU-C was expressed as total number of cells derived per femur, blood CFU-C per 1 ml of plated heparinized whole
blood, and spleen CFU-C per spleen. 14 days after culture, lung parenchymal and BAL fluid cell CFU-C were calculated as per single lung. CFU-C was
performed in duplicate in three independent experiments with n=4 mice per study group in each experiment; CFU-C are expressed as mean 6 SEM
with P,0.05 compared to the Bleo/Saline group shown.
doi:10.1371/journal.pone.0033165.g008
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in ultra-low attachment plates.
Generation of Non-ciliated Pulmonary Epithelial Cells
Two different culture media were employed to generate non-
ciliated pulmonary epithelial cells. EBs were transferred to
adherent culture in 0.1% gelatin-coated tissue culture plates by
limited dispase digestion. One group of EBs was cultured for 12
days in small airways growth medium (SAGM) [i.e., Clonetics
small airways basal medium (Cambrex Bioscience, Walkersville,
MD), bovine pituitary extract 30 mg/ml, insulin 5 mg/ml,
hydrocortisone 0.5 mg/ml, gentamycin sulfate-amphotericin B
0.5 mg/ml, bovine serum albumin 0.5 mg/ml, transferrin 10 mg/
ml, epinephrine 0.5 mg/ml, and recombinant human epidermal
growth factor (rh EGF) 0.5 ng/ml] refreshing media every other
day. Retinoic acid 0.1 ng/ml and triiodothyronine (6.5 ng/ml)
were excluded from SABM following Ali et al. [17]. From the day
12 culture in SAGM, alveolar epithelial cells were flow sorted
based on surface expression of SP-C and AQP-5. The .90% SP-
C
+ and AQP-5
+ flow-sorted cells were grown in the SAGM
medium for 4 more days.
A second group consisted of EBs cultured in bronchiolar
epithelial growth medium (BEGM) [i.e., Clonetics bronchiolar
epithelial basal medium (Cambrex Bioscience), bovine pituitary
extract 30 mg/ml, insulin 5 mg/ml, hydrocortisone 0.5 mg/ml,
gentamycin sulfate-amphotericin B 0.5 mg/ml, retinoic acid
0.1 ng/ml, transferrin 10 mg/ml, triiodothyronine 6.5 ng/ml,
epinephrine 0.5 mg/ml, and rh EGF 0.5 ng/ml] and fed similarly
every other day with fresh medium.
Phenotypic Analysis of Cells
Immunostaining was performed using specific antibodies
conjugated to various fluorochromes such as fluorescein isothio-
cyanate (FITC), phycoerythrin (PE), allophycocyanin (APC),
peridinin chlorophyll protein (PerCP-Cy5.5), and CyChrome
(PE-Cy5 and PE-Cy7). The following BD Biosciences Pharmingen
(San Diego, CA) antibodies were used for cell surface staining:
APC-conjugated CD45 (30F-11), FITC-conjugated CD3 (145-
2C11), PE-Cy5-conjugated B220 (RA3-6B2), APC-conjugated
GR-1 (RB6-8C5), PE-conjugated Mac1 (M1/70), FITC-conjugat-
ed Sca-1, and PE-Cy7-conjugated CD117 (c-kit). PE-Cy5-
conjugated F4/80 [Cl: A3-1 (F4/80)] was obtained from Serotec
Ltd., Oxford, UK. Purified antibodies (clone number/catalog
number/antibody type/concentration) to the following mouse
antigens were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA): SSEA-3 (631/sc-21703/rat monoclonal IgM/200 mg/
ml), SSEA-4 (813-70/sc-21704/mouse monoclonal IgG3/200 mg/
ml), Oct-3/4 (H-134/sc-7705/goat polyclonal IgG/200 mg/ml),
SP-C (C-19/sc-7705/goat polyclonal IgG/200 mg/ml), SP-D
(245-01/sc-59695/mouse monoclonal IgG1/100 mg/ml), AQP-1
(L-19/sc-9878/goat polyclonal IgG/200 mg/ml), AQP-5 (G-19/
sc-9890/goat polyclonal IgG/200 mg/ml), CC-10 (S-20/sc-9773/
goat polyclonal IgG/200 mg/ml), EGF (C-20/sc-1341/goat poly-
clonal IgG/200 mg/ml, VEGF (P-20/sc-1836/goat polyclonal
IgG/200 mg/ml), TTF-1 (G-17/sc-12524/goat polyclonal IgG/
200 mg/ml), CD31 [i.e., platelet endothelial cell adhesion
molecule (PECAM-1); V-16/sc-31045/goat polyclonal IgG/
200 mg/ml], and goat anti-mouse IgG3-FITC (sc-2081/pre-
adsorbed, affinity-purified secondary antibody raised in goat
against mouse IgG3 and conjugated to FITC/400 mg/ml).
Irrelevant isotype-matched antibodies were used as controls.
FITC-conjugated donkey anti-goat or goat anti-rabbit secondary
antibodies were used following incubation with the primary
antibodies. In situ immunostaining with specific FITC- or PE-
conjugated antibodies (and DAPI counterstaining the nuclei of the
cells) or ABC staining (DAKO) was done following the
manufacturer’s protocol. 10
6 cells were taken per sample in
50 ml cell suspension in ice cold PBS (16); 10
5 events were
recorded per sort.
For simultaneous surface and intracellular staining, cell-surface
antigens were stained as follows: 1 ml conjugated antibody/10
6
cells in suspension culture for 30 min on ice. After thorough
washing, cells were fixed in 4% paraformaldehyde in PBS by
vortexing, and incubated at room temperature (RT) for 20 min
followed by permeabilization in either 0.1% Tween-20 or 0.25%
Triton-X. Intracellular staining was performed with readouts
made on a FACScalibur. Different conjugates with widely
separated excitation spectral range were used for separating the
surface vs. intracellular probes (e.g., PE vs. FITC, FITC vs. APC,
APC vs. PE, or APC vs. Cyc-PE).
Cell suspension of 10
6 cells per microfuge tube was prepared per
sample and staining was done by a single step with a master mix of
fluorochrome-conjugated monoclonal antibodies or in some cases
where the primary antibody was not available in a directly
fluorochrome-conjugated form, in two steps of primary unlabeled
antibody followed by cross reactive fluorochrome-conjugated
specific secondary antibody at 4uC for 30 min followed by
rigorous washing (twice) with ice cold PBS. The stained cell
preparation was finally resuspended in 50 ml PBS (with 1% bovine
serum albumin) and read by FACSCalibur (BD Immunocytome-
try Systems, San Jose, CA) by using the CELLQuest program.
Cells were viewed at first keeping at Side Scatter (SSC; X-axis) and
Forward Scatter (FSC; Y-axis) and dead cells gated out by annexin
V staining. CD45
2 cells were then gated out to preempt any blood
cells in the lungs, and 10
5 events were recorded per sample. The
unstained axis was FL-3H. In undifferentiated H7 cells, single
staining with each antibody was done for TTF-1, Oct3/4, SSEA-
3, and SSEA-4. Data from three independent experiments with
each sample sorted in triplicate were pooled, and mean 6 SEM
reported.
Cell Viability
Viable cells were measured by propidium iodide exclusion using
flow cytometry and trypan blue dye exclusion by light microscopy.
Clonogenic Growth of Cells Derived from hES Cells
To quantitate committed progenitors, CFU-C assays were
performed using methylcellulose semisolid media (Stemgenix,
Amherst, NY) supplemented with an additional 50 ng of stem
cell factor per ml (Peprotech, Rocky Hill, NJ) to promote growth of
hematopoietic progenitors. Next, 0.01610
6 cells from lung were
plated on duplicate 35-mm culture dishes and incubated at 37uC
in a 5% CO2-95% air mixture in a humidified chamber for 7 days.
Colonies generated by that time were counted using a dissecting
microscope, and all colony types (i.e., BFU-E, CFU-E, CFU-G,
CFU-GEMM, CFU-GM, and CFU-M) were pooled and reported
as total CFU-C. Aliquots of 1–10610
4 cells were plated per 1 ml
of semisolid methylcellulose (CFU-lite with Epo, Miltenyi Biotech,
or complete human methycellulose medium, Stem Cell Technol-
ogies, Vancouver, BC, Canada). CFU-C frequency was scored
morphologically after 10 to 14 days in culture at 37uC, 5% CO2,
in a humidified incubator.
Mouse Model of Pulmonary Fibrosis and Transplantation
of Differentiated H7 hES Cells
Rag2cC double KO mice (Rac2cC
2/2) from Taconic
(Hudson, NY) [47] were housed under specific pathogen-free
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bleomycin in 40 ml saline was administered (day 0). On day 7
after bleomycin treatment, mice were irradiated sub-lethally
(300R) prior to transplant to minimize the possibility of graft
rejection and then transplanted with 10
5 differentiated hES cells
intratracheally in a 50 ml volume. Transplant groups consisted of
cells from day 12 in culture with SAGM alone (Bleo/hES+SAGM
group) or with treatment of 5 mM ICG-001 for 6 h at 37uC (Bleo/
hES+SAGM+ICG-001 group). Before transplantation, cells were
incubated for 30 min at 37uC with a pro-survival cocktail
composed of 10 mM ZVAD-FMK (Promega, Madison, WI),
50 nM Bcl-XL BH4 (Transduction Laboratories, Lexington, KY),
0.2 mM cyclosporine A (Sigma-Aldrich Corporation), 100 ng/ml
recombinant mouse insulin-like growth factor-1 (IGF-1, Santa
Cruz Biotechnologies), and 50 mM of the KATP channel opener
pinacidil (Sigma-Aldrich Corporation) [48,49]. The cells were
heat-shocked for 30 min at 42uC in a water bath followed by
return to 37uC before transplantation. The pro-survival cocktail
was not included in the injectate. Control groups consisted of mice
treated intratracheally (50 ml) with either saline (Saline group) or
bleomycin (Bleo/Saline group) on day 0 and saline on day 7.
Mice were sacrificed on day 14 with the total number of cells
and CFU-C in bone marrow, spleen, blood, lungs, and
bronchoalveolar lavage (BAL) fluid determined. Both femurs were
flushed to obtain bone marrow. After intraorbital bleeding, blood
counts were extrapolated to a total volume of 2 ml (i.e., total blood
volume in 20 gm mouse). Parenchymal cells of a single lung were
obtained by enzymatic digestion with 0.1% collagenase type IV for
60 min at 37uC. Cell subsets in BAL fluid (i.e., macrophages,
lymphocytes, and neutrophils as a percentage of total leukocytes)
were quantitated by monoclonal antibodies conjugated with
fluorochromes gated as CD45
+ cells in FACScan. Analysis of
single cell suspensions of cell populations was done by enzymatic
digestion with 0.1% collagenase type IV for 60 min at 37uC for
detachment from lung tissue, followed by cell counting in Coulter
counter and cell subset identification and quantitation by flow
cytometry. Lung tissue was extracted for total RNA for qPCR and
sections obtained for histochemistry/immunocytochemistry.
Analysis of Colony Forming Units in Tissue
Compartments
The number of bone marrow CFU-C counted 7 days after
culture in semi-solid methylcellulose supplemented with 50 ng/ml
stem cell factor was calculated as per single femur. Typically
50,000 cells were plated per ml. The number of blood CFU-C
grown in semi-solid methylcellulose medium for 7 days was
determined per ml of plated heparinized whole blood. The
number of splenic CFU-C grown after 7 days in methylcellulose
with 500,000 splenocytes plated was extrapolated to total number
of splenocytes in one spleen. The number of CFU-C grown after
14 days of culture in semi-solid methylcellulose medium plated
with 1610
6 cells from dispase-digested mouse lung was calculated
on total number of cells obtained from a single lung. The number
of CFU-C grown after 14 days of culture in semi-solid
methylcellulose medium plated with 1610
6 BAL fluid cells was
calculated on the total number of cells obtained from BAL fluid
from a single lung. The cells were derived from Rag2cC double
knockout mice that were sub-lethally irradiated prior to xenograft
transplantation with human H7 cells. Thus, progenitor numbers
were lower than expected because a) the recipients were severely
immunocompromised, b) they were irradiated already depleting
progenitor reservoir in their tissues, and c) the 1 week period of
homing and engraftment allowed in the experiment was very short
to reduce the possibility of teratoma formation. Cells were counted
on a Leica DMIL inverted microscope (106) and photographed
with a Canon Power Shot S50 digital camera; at least 40-cell
colonies were considered.
RNA Isolation
Total RNA was extracted from cultured cells (,500/sample) by
PicoPure RNA isolation kit (Arcturus, Mountain View, CA). For
isolation of total lung RNA, 600 ml of lysing buffer was added to
disrupted lung tissue in a 1.5-ml microfuge tube, and lysate was
loaded onto a QIAshredder column and centrifuged for 2 min at
13,000 rpm. The homogenized lysate was then mixed with 600 ml
of 70% ethanol and applied to an RNeasy mini spin (QIAGEN
Inc, Valencia, Calif) column for centrifugation for 15 sec at
13,000 rpm. Next, 700 ml of buffer RW1 and buffer RPE was
added and centrifuged sequentially for washing twice. Then, 60 ml
of ribonuclease-free water was used to elute total RNA from the
RNeasy mini spin column. All total RNA used in the experiments
was pure as determined by the ratio of absorbance (A) at 260 vs.
280 nm (A260/A280 ratio .1.9) and stored at 280uC.
qPCR Analysis
cDNA was made using Superscript III system from Invitrogen
and qPCR performed. For qPCR performed in duplicate tubes,
the PCR reaction solution contained 0.5 mg of total RNA, 6 mM
magnesium chloride, and 0.5 mM of each primer (primer
oligonucleotide sequences shown are in Table S1 in the online
supporting information. Other components in the reverse
transcriptase PCR master mix included buffer, enzyme, SYBR
Green I, and deoxyribonucleotide triphosphate. For reverse
transcription, the 20 ml of reaction capillaries were incubated at
50uC for 2 min followed by denaturation at 95uC for 10 min.
PCR by initial denaturation at 95uC for 15 sec was followed by
annealing at 60uC for 1 min, repeated 45 cycles. Finally, a melting
curve analysis was performed by following the final cycle with
incubation at 95uC for 15 sec, 60uC for 15 sec, and 95uC for
15 sec. Negative control samples for the qPCR analysis that
contained all reaction components except RNA, were performed
simultaneously to determine when the nonspecific exponential
amplification cycle number was reached. Primers were synthesized
by the University of Washington Biochemistry services using
Primer Express software. qPCR was performed by the compar-
ative Ct method with SYBR Green PCR core reagents (Applied
Biosystems, Foster City, CA) and analyzed using Applied
Biosystems 7900HT Real-Time PCR System software SDS 2.2.1.
Analysis of Collagen Content in Lung
Masson’s trichrome and Sirius red stains were used to detect
collagen deposition in the lungs [50]. Total amount soluble
collagen in the lung was determined as the mean of triplicate tubes
for each sample by the Sircol
TM quantitative dye-binding collagen
assay (Biocolor Ltd., Newtownabbey, Northern Ireland, UK) [50].
Detection of Human Cells in Mouse Lung
Three methods were employed to detect engrafted derived cells
in mouse lung: 1) detection of Alu sequence in transplanted mouse
lung RNA was performed by qPCR, using the following primers:
GTCAGGAGATCGAGACCATCCC (forward sequence) and
TCCTGCCTCAGCCTCCCAAG (reverse sequence), Alu ele-
ments are specific to the human genome and are present at ,1
million copies/diploid sequence, making them a sensitive indicator
of human cell content. 2) Immunocytochemistry was performed
using a mouse anti-human nuclei IgG1 monoclonal antibody
(clone 235-1, catalog number: MAB1281; Millipore Corporation,
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diffuse nuclear pattern with no reactivity against mouse in
immunohistochemistry. 5 mm thick sections of 2% paraformalde-
hyde-fixed OCT-embedded frozen lung tissue were blocked with
goat serum at RT for 1 h followed by incubation with the anti-
human nuclei antibody overnight at 4uC. After washing in PBS
and incubation with secondary goat anti-mouse antibody for 1 h
at RT, ABC staining (Vector Laboratories Inc.) was performed
following the manufacturer’s protocol; and 3) in situ hybridization
in mouse transplanted lung sections with human-specific pan-
centromeric probe was performed in 8 mm thick, methyl carnoy-
fixed paraffin-embedded lung sections following the protocol
described previously [48].
Immunohistochemistry
For immunohistochemistry with non-conjugated antibodies,
paraffin-embedded lung tissue was deparaffined in xylene, and
rehydrated in 100% and 95% ethyl alcohol. Endogenous
peroxidase was quenched in methanol with 0.3%–3% hydrogen
peroxide for 30 min at RT. Blocking was done for 1 h at RT in
PBS containing Ca
2+ and Mg
2+ with 1.5% non-immune serum of
the species in which the secondary antibody was made. The
primary antibody was incubated for 1 h at RT followed by 3
washes in PBS at RT. The secondary antibody was applied and
incubated. ABC staining (Vector Laboratories Inc, Burlingame,
CA) was performed following the manufacturer’s protocol.
Immunofluorescence Microscopy
Photographs were taken with a Leica DMIL inverted
microscope (Leica Microsystems GmbH, Wetzlar, Germany) and
a Zeiss ApoTome (Carl Zeiss Microimaging GmbH, Go ¨ttingen,
Germany). IF photographs were taken with a Zeiss Axiovert
200 M microscope and Axiocam MRm and merged using
Axiovision 4.6 software.
Transmission electron microscopy
For transmission electron microscopy, the cells were fixed with
warm K Karnovsky’s fixative (1:1 with buffer) after removal of the
culture medium and washed with 0.1 M cacodylate buffer for
10 min. After the fixative was removed, the sections were
incubated in pure fixative for 30–60 min. The cells were gently
scraped using a standard Sarstedt cell scraper, and placed into
Eppendorf tubes and spun down at 1500 rpm for 5 min. After
addition of new fixative, the cells were resuspended and stored at
4uC overnight. After 3 washes for 5 min in 0.1 M cacodylate
buffer, cells were centrifuged and 1% osmium tetroxide in 0.1 M
cacodylate buffer added and incubated for 1–2 h at 4uC followed
by 3 washes in 0.1 M cacodylate buffer for 5 min. Dehydration
was done in graded series of ethyl alcohol (i.e., 50%, 70%, 95%,
26100%) for 15 min and two washes in propylene oxide for
15 min. Embedding was done in 1:1 propylene oxide/Epon resin
overnight with Eppendorf tubes capped. The next day, cells were
centrifuged and fresh 100% Epon resin added for 2–4 h.
Polymerization was done in a 60uC oven overnight in Eppendorf
tubes. 70–100 nm thick sections were made on a copper grid using
a Leica EM UC6 ultramicrotome (Leica Microsystems GmbH,
Wetzlar, Germany). Sections were viewed in a JEOL JEM-1230
transmission electron microscope (JEOL Ltd., Tokyo, Japan),
equipped with an Ultrascan 1000
TM 2k62k CCD camera (Gatan,
Inc., Pleasanton, CA), and photomicrographs taken using Gatan
Digital Microscope software.
Statistical Analysis
The data are reported as mean 6 SEM. Statistical differences
among samples were tested by Student’s t test. P value,0.05 was
considered statistically significant.
Supporting Information
Figure S1 FACS scattergrams of hES cells differentiated
to lung epithelial cell-specific lineages. EBs were differen-
tiated in EB medium over 10 days and then cells cultured over 12
days in SAGM as described in Figure 3. FL-3H denotes gating
around cells negative for all pluripotent markers. a day 1, b, c day
8, and d day 12 scattergrams are shown. Cells double positive for
SP-C and non-pluripotent markers were considered as lung
lineage-specific differentiated cells consistent with an AEII
phenotype. The data shown are representative of n=3 indepen-
dent experiments. The percentage of cells gated in each quadrant
is shown for expression of a SP-C (UL, 3.58%; UR, 0.67%; LL,
88.72%; and LR, 7.03%), b: SP-C (UL, 0.58%; UR, 0.47%; LL,
58.38%; and LR, 40.57%), c: SP-C and CC-10 (UL, 3.33%; UR,
3.70%; LL, 58.77%; and LR, 34.20%), and d: SP-C and TTF-1
(UL, 0.01%; UR, 32.42%; LL, 0.12%; and LR, 67.45%).
(TIF)
Figure S2 Effect of ICG-001 on cell morphology of hES
cells in SAGM. H7 hES cells differentiated in SAGM were
incubated with 5 mM ICG-001 in culture medium for 12 h as
described in Figure 4, and cell morphology was assessed a before,
and b, c after incubation with ICG-001. a, b 106 and c 406
magnification. The data shown are representative of n=3
independent experiments.
(TIF)
Figure S3 Effect of ICG-001 on hES cells differentiated
in BEGM. Single cell suspensions of human H7 hES cells
differentiated in BEGM and incubated in the a–d (open bars), e
absence or a–d (solid bars), f presence of 5 mM ICG-001 in
culture medium for 12 h underwent FACS to identify percentage
by a intracellular and b surface expression of surface markers for
AEII cells (SP-C
+), AEI cells (AQP-5
+), and Clara cells (CC-10
+)
and expression of c pluripotent markers (c-kit
+, Lin
2, Oct3/4
+)
and d growth factors (EGF
+, VEGF
+, IGFII
+). The percent
positive cells of total cells in culture are shown as mean 6 SEM
(triplicate sampling from three independent experiments). P,0.05
values in ICG-001-treated group vs. untreated group are shown. e,
f 406magnification.
(TIF)
Table S1 Mouse primers for qPCR.
(DOCX)
Table S2 P,0.05 for Figure 2: ‘‘Sequential downregu-
lation of stem cell-specific surface proteins’’ panels e
and f. Figure 2e data points where P,0.05. Figure 2f data points where
P,0.05.
(DOCX)
Table S3 P,0.05 for Figure 3: ‘‘Phenotypic analysis and
ultrastructure of hES cells differentiated to lung epithe-
lial cell-specific lineages’’ panels a, b, e, and f. Figure 3a
marker data points where P,0.05. Figure 3b marker data points where
P,0.05. Figure 3e marker data points where P,0.05. Figure 3f marker
data points where P,0.05. NS, Not Significant.
(DOCX)
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